Foreign pharma firms continue to right-size their commercial engine in India as they implement strategic shifts and leverage digitization to drive efficiencies in an ultra-competitive market dominated by domestic players.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?